TrialJournal of clinical oncology : official journal of the American Society of Clinical Oncology2018

CheckMate-032 Study: Efficacy and Safety of Nivolumab and Nivolumab Plus Ipilimumab in Patients With Metastatic Esophagogastric Cancer.

Yelena Y Janjigian et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.